Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data

Abstract

BackgroundA plethora of clinical studies have assessed the benefits of implantable cardioverter defibrillators (ICDs) and supported their use in clinical practice. However, evidence on the safety and efficacy of ICDs appears insufficient to support expansion of their use in clinical practice, and more information on their impact in real life settings is warranted. This paper aims to investigate the impact of ICDs using a large administrative dataset reflecting actual clinical practice.MethodsData were obtained from the hospital discharge database of the Friuli Venezia Giulia region in Italy containing patient-level information on 169,488 cases. Data on mortality outside hospital were obtained from regional sources. Exact matching method was used to estimate the outcomes associated with ICDs: mortality, length of stay, re-hospitalization and regional expenditure. The method was applied in two steps. First, patients with ICDs were matched with those without using the following: age class (by 5 years), gender, year of admission, type of admission (day hospital vs. ordinary) and primary diagnosis. In the second step, matching included also Charlson Comorbidities Index. Exact matching average treatment effect on the treated (ATT) was used as a main measure of impact.ResultsCompared with matched controls, treatment with ICDs was associated with lower mortality (absolute risk reduction 10.6% at 1 year and 8.3% at 2 and 8.4% at 3 years, p < 0.001 and hazard ratio 0.80, p < 0.001), greater regional expenditure at index hospitalization (ATT: €9459.64, p < 0.001) and during follow up (ATT: €1707.29, p < 0.001) and higher re-hospitalization rate (ATT: 0.53, p < 0.001). No significant difference was found for length of stay (9.07 vs. 8.86 days). The results were maintained after more restrictive matching was applied.ConclusionsAssessing the impact of innovative, expensive medical technologies on the basis of real world data is warranted, especially when there are barriers to implementation. Hospital administrative datasets can be of great value when a technology such as the ICD is implemented in a relatively small sample of patients, to allow use of exact matching techniques.

Investigating Regional Variation of Cardiac Implantable Electrical Device Implant Rates in European Healthcare Systems: What Drives Differences?

“…The present study is based on the use of administrative data for exploring implant rates but did not assess outcome, as was carried out in other studies using hospital discharge data (Ghislandi et al ., ). The accuracy of the administrative data that we consider can be variable, for complex reasons that cannot be analyzed in depth.…”

Cardiac device therapy in patients with left ventricular dysfunction and heart failure: ‘real‐world’ data on long‐term outcomes (mortality, hospitalizations, days alive and out of hospital)

“…The assessment of the burden of all‐cause hospitalizations is not an easy task to distinguish in observational studies with long follow‐up and, in this perspective, the use of administrative data even to measure the DAOH%, as done in this study, could be considered an important tool for having a full picture of all the hospitalizations . A previous study, based on analysis of administrative datasets, was focused on the value of this type of approach in the specific setting of use of ICDs in the real world …”

Provider Experience and the Comparative Safety of Laparoscopic and Open Colectomy

“…We generated average outcome rates for each procedure using marginal means. Finally, from the second‐stage model, we report odds ratios and average treatment effects (ATE) for laparoscopy relative to open surgery for each outcome (Ghislandi, Torbica, and Boriani ). The average treatment effect was calculated using the following method, where X p is a binary variable for laproscopic (1) or open (0) colectomy.…”